Skip to content

LENSIMMO

Active
Private limited companyfounded 2016active for 10 yearsHelststraat 150-159, 2630 Aartselaar, BelgiumKBO/BCE: BE 0664.800.584

Acts, filings and financial milestones

Deadline for the 2026 accounts: 30-04-2027
2026
16-07
Gazette deed Permanent representative: Patrick Saerens
Court decision3 points ▸
  • Court decision, 25-06-2026
  • Board composition, Patsaer Consulting S.à R.I.-S (sole director)
  • Permanent representative, Patrick Saerens

Open the act in the Belgian Official Gazette

18-04
NBB filing Annual accounts 2025 filedPDF
abbreviated format · 12 days before the deadline
2025
05-12
Gazette deed Resignation: Patsaer Consulting SARL (director)
Appointment: Landepe BV (sole director) · Director discharge4 points ▸
  • General meeting, 17-11-2025
  • Director resignation, Patsaer Consulting SARL (director)
  • Director discharge, Patsaer Consulting SARL
  • Director appointment, Landepe BV (sole director)

Open the act in the Belgian Official Gazette

22-07
Gazette deed 1 director appointed, 1 director resigning
Resignation: CommV LANDERLOO & PARTNERS (director) · Permanent representatives: Pedro Landerloo and Patrick Saerens · Appointment: Patsaer Consulting Sàrls (manager)5 points ▸
  • General meeting, 04-06-2025
  • Director resignation, CommV LANDERLOO & PARTNERS (director (not named in the articles))
  • Permanent representative, Pedro Landerloo
  • Director appointment, Patsaer Consulting Sàrls (manager (not named in the articles))
  • Permanent representative, Patrick Saerens

Open the act in the Belgian Official Gazette

30-04
NBB filing Annual accounts 2024 filedPDF
abbreviated format · on the deadline day
2024
30-09
Financial Back to profitnet €15,691
The net result is €15,691, after 2 loss-making years.
30-04
NBB filing Annual accounts 2023 filedNBB
full format · on the deadline day
30-04
NBB filing Annual accounts 2023 filedPDF
abbreviated format
2023
28-12
Gazette deed Demerger: PHARMALENS splits off to LENSFACTORY
Company renamed from PHARMALENS to LENSIMMO · Change of role: Landerloo & Partners, from manager to director · Permanent representative: LANDERLOO Pedro43 points ▸
  • General meeting, 18-12-2023, mentioned 2 times in the deed
  • Demerger, “partiële splitsing door inbreng van gedeelte van vermogen, artikel 12:8 juncto 12:59 WVV” (deed in Dutch)
  • Other provision, “vereenvoudigde procedure zonder verslagen, artikel 12:65 WVV” (deed in Dutch)
  • Auditor report, “artikel 5:133 WVV, inbreng in natura in PHARMALENS” (deed in Dutch)
  • Other provision, “agenda en toezending splitsingsvoorstel, onverwijld afschrift toegezonden” (deed in Dutch)
  • Other provision, “zetel, terbeschikkingstelling stukken en verzaking tussentijdse cijfers” (deed in Dutch)
  • Director resignation, Landerloo & Partners (manager)
  • Director appointment, Landerloo & Partners (director (not named in the articles))
  • Permanent representative, LANDERLOO Pedro
  • Other provision, “tweede beslissing kennisname splitsingsvoorstel, afschrift splitsingsvoorstel met stempel ondernemingsrechtbank te Antwerpen toevertrouwd aan ondergetekende not…” (deed in Dutch)
  • Other provision, “derde beslissing afstand verslaggeving, artikel 12:65 WVV” (deed in Dutch)
  • Other provision, “vierde beslissing kennisname verslagen inbreng in natura, artikel 5:133 WVV” (deed in Dutch)
  • The act holds 31 more points.

Open the act in the Belgian Official Gazette

06-11
Gazette deed Demerger proposal: LENSFACTORY splits off to PHARMALENS
Appointment: Guy Parmentier (statutory auditor) · Incorporation · Capital36 points ▸
  • Demerger, “partiële splitsing, onderscheiden deel van vermogen” (deed in Dutch)
  • Board meeting, “opmaak en goedkeuring voorstel tot partiële splitsing, Bestuursorgaan van de Naamloze Vennootschap LENSFACTORY” (deed in Dutch)
  • Other provision, “tijdstabel en tussentijdse cijfers LENSFACTORY, art.12:41 WVV” (deed in Dutch)
  • Other provision, “aandeelhouderschap voor afsplitsing, aandelen af te splitsen vennootschap en aandelen overnemende vennootschap in handen van dezelfde vennoten” (deed in Dutch)
  • Incorporation, 10-12-2002
  • Other provision, 21-03-2016
  • Board composition, Alain Aelbrecht (director)
  • Board composition, Landerloo Partners CommV (director), mentioned 2 times in the deed
  • Board composition, Patsaer Consulting SARLS (director)
  • Other provision, “vertegenwoordiger, vertegenwoordiging” (deed in Dutch), mentioned 2 times in the deed
  • Incorporation, 19-10-2016
  • Capital, €75,000
  • The act holds 24 more points.

Open the act in the Belgian Official Gazette

30-09
Financial Equity above €200,000equity €225,273
Equity rises from -€44,002 to €225,273.
21-04
NBB filing Annual accounts 2022 filedPDF
abbreviated format · 9 days before the deadline
Show earlier events
2022
28-04
NBB filing Annual accounts 2021 filedPDF
abbreviated format · 2 days before the deadline
2021
30-09
Financial Back to profitnet €21,919
The net result is €21,919, after 2 loss-making years.
29-04
NBB filing Annual accounts 2020 filedPDF
abbreviated format · 1 day before the deadline
2020
06-05
NBB filing Annual accounts 2019 filedPDF
micro format · 6 days late
2019
28-03
NBB filing Annual accounts 2018 filedPDF
micro format · 33 days before the deadline
2016
21-10
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

LENSIMMO was incorporated on 19 October 2016.1 Total assets rose from €38,158 in 2019 to €351,529 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2019 and 2025

Next steps